ReviewCells2026
Cerebrospinal Fluid as a Window into Neuroimmune Responses During Brain Infection.
Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Understanding neuroimmune responses during brain infections remains challenging because the site of disease (i.e., the brain) is difficult to access, immune responses within the central nervous system (CNS) are spatially and temporally compartmentalized, and peripheral immune cells have largely served as a proxy for the neuroimmune response. Cerebrospinal fluid (CSF) occupies a unique anatomical and immunological position at the interface between the brain parenchyma, CNS border compartments, and the peripheral immune system, making it an important window through which neuroinflammatory processes can be investigated in living patients. In this review, we examine evidence from CNS infections, with particular emphasis on tuberculous meningitis, demonstrating that CSF contains cellular and transcriptional profiles that differ from those observed in peripheral blood and vary according to the anatomical sampling site. We consider how CNS-resident cells, border-associated immune populations, and recruited leukocytes contribute to the neuroimmune environment of CSF. Importantly, we distinguish evidence derived from cells directly recovered from CSF from soluble biomarkers that may reflect activity in parenchymal or border compartments, and from cellular processes inferred from transcriptomic studies. We also discuss how CSF sampling and analytical approaches influence interpretation and highlight the potential of high-dimensional profiling to resolve compartmentalized neuroimmune responses during CNS infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.